Highly Leveraged Dow Jones Biotechnology Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
64.61 B
(0.14)
 1.69 
(0.24)
2ABBV AbbVie Inc
59.38 B
(0.05)
 2.07 
(0.10)
3GILD Gilead Sciences
24.99 B
 0.20 
 1.42 
 0.28 
4BIIB Biogen Inc
7.34 B
(0.25)
 1.36 
(0.34)
5CRL Charles River Laboratories
3.07 B
 0.04 
 2.56 
 0.10 
6REGN Regeneron Pharmaceuticals
2.7 B
(0.37)
 1.74 
(0.65)
7ALNY Alnylam Pharmaceuticals
2.68 B
 0.01 
 2.15 
 0.02 
8ILMN Illumina
2.26 B
 0.08 
 2.28 
 0.18 
9HALO Halozyme Therapeutics
1.5 B
(0.08)
 3.78 
(0.29)
10IONS Ionis Pharmaceuticals
1.45 B
(0.15)
 2.63 
(0.40)
11BMRN Biomarin Pharmaceutical
1.1 B
(0.19)
 2.58 
(0.50)
12VRTX Vertex Pharmaceuticals
808.4 M
(0.01)
 1.67 
(0.02)
13UTHR United Therapeutics
700 M
 0.05 
 1.69 
 0.09 
14NBIX Neurocrine Biosciences
428.4 M
 0.02 
 1.66 
 0.03 
15BLUE Bluebird bio
424.62 M
(0.07)
 5.31 
(0.37)
16TECH Bio Techne Corp
419.54 M
 0.05 
 2.33 
 0.12 
17MNKD MannKind Corp
382.38 M
 0.08 
 1.71 
 0.14 
18ALKS Alkermes Plc
372.19 M
 0.04 
 2.35 
 0.10 
19OPK Opko Health
326.56 M
(0.02)
 2.39 
(0.05)
20NVAX Novavax
229.08 M
(0.08)
 5.54 
(0.43)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.